New rules make it easier for FDA to crack down on unscrupulous stem cell providers, doctors hope

Long considered to be the medicine of tomorrow, the Food and Drug Administration (FDA) describes stem cell therapies on its website as treatments that “may offer the potential to treat diseases or conditions for which few treatments exist.”